药物对比
Pioglitazone vs Lixisenatide
比较 Pioglitazone（Actos）与 Lixisenatide（Soliqua）治疗2型糖尿病：口服TZD胰岛素增敏剂 vs 注射用GLP-1激动剂。评估疗效、心脏风险、胃肠道影响及患者因素。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients needing add-on therapy who must weigh oral convenience against injectable GLP-1 benefits and cardiovascular risks.
结论
Pioglitazone and Lixisenatide are not interchangeable; the better choice depends on heart health, injection preference, and specific glycemic targets.
全部药物对比